ML364 10 mg | 100.00%
TargetMol
ML364 is an inhibitor of ubiquitin specific peptidase 2 (USP2) and can be used for the research of breast cancer.
More Information Supplier PageML364
Search Results
Y16 5 mg | Purity Not Available
TargetMol
Y16 is a G-protein–coupled Rho GEFs inhibitor; works synergistically with Rhosin/G04 in inhibiting LARG-RhoA interaction, RhoA activation, and RhoA-mediated signaling functions.
More Information Supplier PageY16
Y16 10 mg | Purity Not Available
TargetMol
Y16 is a G-protein–coupled Rho GEFs inhibitor; works synergistically with Rhosin/G04 in inhibiting LARG-RhoA interaction, RhoA activation, and RhoA-mediated signaling functions.
More Information Supplier PageY16
Epacadostat 5 mg | 98.56%
TargetMol
Epacadostat is an oral-available inhibitor of indoleamine 2, 3-dioxygenase (IDO1), increasing the proliferation and activation of various immune cells and reducing tumor-associated regulatory T cells.
More Information Supplier PageEpacadostat
Epacadostat 50 mg | 98.56%
TargetMol
Epacadostat is an oral-available inhibitor of indoleamine 2, 3-dioxygenase (IDO1), increasing the proliferation and activation of various immune cells and reducing tumor-associated regulatory T cells.
More Information Supplier PageEpacadostat
ML364 50 mg | 100.00%
TargetMol
ML364 is an inhibitor of ubiquitin specific peptidase 2 (USP2) and can be used for the research of breast cancer.
More Information Supplier PageML364
ML364 5 mg | 100.00%
TargetMol
ML364 is an inhibitor of ubiquitin specific peptidase 2 (USP2) and can be used for the research of breast cancer.
More Information Supplier PageML364
PLX8394 10 mg | 100.00%
TargetMol
PLX8394 is an orally active inhibitor of serine/threonine-protein kinase B-Raf (BRAF) protein. PLX8394 can selectively bind to and inhibit the activity of both wild-type and mutated forms of BRAF, then inhibit the proliferation of tumor cells which express mutated forms of BRAF. PLX8394 appears to be effective against tumors that express multiple mutated forms of […]
More Information Supplier PagePLX8394
NIH-12848 5 mg | 99.84%
TargetMol
NIH-12848 is a putative inhibitor of phosphatidylinositol 5-phosphate 4-kinase Îł (PI5P4KÎł) with an IC50 of 1 ÎĽM.
More Information Supplier PageNIH-12848
NIH-12848 50 mg | 99.84%
TargetMol
NIH-12848 is a putative inhibitor of phosphatidylinositol 5-phosphate 4-kinase Îł (PI5P4KÎł) with an IC50 of 1 ÎĽM.
More Information Supplier PageNIH-12848